Please assess the completion status of the following clinical trial:

Trial Title: Intravitreal Injections of Melphalan for Retinoblastoma

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Retinoblastoma that has not responded to chemotherapy~* Retinoblastoma that has vitreal seeding~Exclusion Criteria:~* previous failure of IVit Melphalan

- Gender: ALL
- Minimum Age: None
- Maximum Age: 20 Years
- Healthy Volunteers: f

Study Arms:
- IVit Treatment group (Type: EXPERIMENTAL): Intravitreal injections of Melphalan

Based on this trial design, predict the completion outcome and termination type (if applicable).